Drugs containing reduced of vitamin b2
AssigneeEisai R&D Management Co., Ltd.
InventorsSeiichi Araki, Mamoru Suzuki, Yoshiki Sugihara, Toshio Toyosawa
Life of this patent
Estimating the term…
Abstract
Preventives and remedies with an excellent immunopotentiating effect for infections, sepsis and/or septic shock. More specifically, immunopotentiators/preventitives and remedies for infections and remedies for sepsis and septic shock comprising as the active ingredient reduced riboflavin and/or reduced riboflavin derivatives or pharmacologically acceptable salts thereof.
Claims18
An immunopotentiator/infection defense and/or treatment medicine comprising reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof as the active ingredient.
A medicine for the prevention and/or treatment of sepsis comprising reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof as the active ingredient.
A medicine for preventing or treating septic shock comprising reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof as the active ingredient.
A medicine for preventing or treating malaria comprising reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof as the active ingredient.
A method of immunopotentiation/infection prevention or of prevention and/or treatment of sepsis, septic shock or malaria comprising administering to a subject a pharmacologically effective amount of reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof.
The use of reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof for the production of an immunopotentiator/infection defense and/or treatment medicine or a medicine for the prevention and/or treatment of sepsis, septic shock or malaria.
A method of immunopotentiation/infection prevention or of prevention and/or treatment of sepsis, septic shock or of malaria by the action of reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof that is produced in vivo, which comprises administering a subject a pharmacologically effective amount of riboflavin and/or a riboflavin derivative, or pharmacologically acceptable salt thereof.
An immunopotentiator/infection defense and/or treatment medicine or a medicine for the prevention and/or treatment of sepsis, septic shock or malaria comprising reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof, that is produced in vivo through administering a subject riboflavin and/or a riboflavin derivative, or pharmacologically acceptable salt thereof, as the active ingredient.
The use of riboflavin and/or a riboflavin derivative, or pharmacologically acceptable salt thereof in the production of an immunopotentiator/infection defense and/or treatment medicine or a medicine for the prevention and/or treatment of sepsis, septic shock or malaria by the action of reduced riboflavin and/or a reduced riboflavin derivative, or pharmacologically acceptable salt thereof, that is created in vivo, which comprises administering riboflavin and/or a riboflavin derivative, or pharmacologically acceptable salt thereof.
Dependencies are inferred from the claim text.